144 related articles for article (PubMed ID: 38486828)
1. Autologous hematopoietic stem cell transplant at a tertiary care centre in India: achieving comparable outcomes with adaptations.
Gupta AK; Meena JP; Seth R; Naranje P; Mohanty S; Coshic P
Blood Cell Ther; 2024 Feb; 7(1):25-32. PubMed ID: 38486828
[TBL] [Abstract][Full Text] [Related]
2. Second stem cell transplantation for treatment of relapsed/refractory multiple myeloma after first autologous stem cell transplant: A 15-year retrospective institutional analysis.
Yadav N; Mirgh SP; Aggarwal M; Agrawal N; Mehta P; Khushoo V; Kapoor J; Bhatia N; Agrawal P; Ahmed R; Bhurani D
Indian J Cancer; 2023; 60(3):316-324. PubMed ID: 37787191
[TBL] [Abstract][Full Text] [Related]
3. Sustained Hematopoietic Engraftment Potential after Prolonged Storage of Cryopreserved Hematopoietic Stem Cells Used in Salvage Autologous Stem Cell Transplantation.
Makhani SS; Oza SP; Reich-Slotky R; Munshi PN; Biran N; Donato ML; Siegel DS; Vesole DH; Naam S; Rowley SD
Transplant Cell Ther; 2022 Jun; 28(6):306.e1-306.e7. PubMed ID: 35248777
[TBL] [Abstract][Full Text] [Related]
4. Autologous stem cell transplant for high-risk neuroblastoma: Achieving cure with low-cost adaptations.
Jain R; Hans R; Totadri S; Trehan A; Sharma RR; Menon P; Kapoor R; Saxena AK; Mittal BR; Bhatia P; Kakkar N; Srinivasan R; Rajwanshi A; Varma N; Samujh R; Marwaha N; Bansal D
Pediatr Blood Cancer; 2020 Jun; 67(6):e28273. PubMed ID: 32196923
[TBL] [Abstract][Full Text] [Related]
5. Pattern of autologous stem cell transplants at a tertiary care government hospital, with emphasis on transplant outcomes with pre-harvest CD34+ level.
Dolai TK; De R; Sen A; Baul SN; Mitra S; Bhattacharya S; Mondal I; Mukhopadhyay K; Chattopadhyay A; Dutta S; Mandal PK
Blood Cell Ther; 2022 Feb; 5(1):16-26. PubMed ID: 36714265
[TBL] [Abstract][Full Text] [Related]
6. Autologous Stem Cell Transplantation in Elderly Lymphoma Patients in Their 70s: Outcomes and Analysis.
Sun L; Li S; El-Jawahri A; Armand P; Dey BR; Fisher DC; Jacobsen ED; Jacobson CA; LaCasce AS; McAfee SL; Spitzer TR; Chen YB; DeFilipp Z
Oncologist; 2018 May; 23(5):624-630. PubMed ID: 29284757
[TBL] [Abstract][Full Text] [Related]
7. High-dose chemotherapy and peripheral hematopoietic stem cell transplantation in relapsed/refractory Hodgkin's lymphoma.
Kelta M; Zekri J; Abdelghany E; Rehman JU; Khan ZA; Al-Saadi R; Dada R
Tumori; 2018 Dec; 104(6):471-475. PubMed ID: 28009428
[TBL] [Abstract][Full Text] [Related]
8. Efficacy and safety of autologous transplant with non-cryopreserved peripheral blood stem cells in myeloma and lymphoma in Algeria. 10 years' experience.
Bekadja MA; Entasoltan B; Amani K; Ouldjeriouat H; Osmani S; Bouchama S; Charef L; Arabi A; Brahimi M; Bouhass AR; Yafour N
Tunis Med; 2022 Novembre; 100(11):762-768. PubMed ID: 37551517
[TBL] [Abstract][Full Text] [Related]
9. The influence of high-efficiency particulate air filtration on mortality among multiple myeloma patients receiving autologous stem cell transplantation.
Tsai CK; Yeh CM; Hong YC; Chen PM; Liu JH; Gau JP; Liu CJ
Sci Rep; 2021 Jun; 11(1):11789. PubMed ID: 34083620
[TBL] [Abstract][Full Text] [Related]
10. Progression-Free Survival at 24 Months as A Landmark After Autologous Stem Cell Transplant in Relapsed or Refractory Diffuse Large B-cell Lymphoma.
Tun AM; Maliske S; Wang Y; Inwards DJ; Habermann TM; Micallef I; Porrata L; Paludo J; Bisneto JV; Rosenthal A; Kharfan-Dabaja MA; Ansell SM; Nowakowski GS; Farooq U; Johnston PB
Transplant Cell Ther; 2022 Sep; 28(9):610-617. PubMed ID: 35752441
[TBL] [Abstract][Full Text] [Related]
11. Long-Term Results with Thiotepa-Containing Conditioning Regimens for Autologous Stem Cell Transplantation.
Cohen YI; Lebel E; Zimran E; Shaulov A; Stepensky P; Grisariu S; Avni B
Transplant Cell Ther; 2023 Aug; 29(8):505.e1-505.e8. PubMed ID: 37160229
[TBL] [Abstract][Full Text] [Related]
12. The availability of HEPA-filtered rooms and the incidence of pneumonia in patients after haematopoietic stem cell transplantation (HSCT): results from a prospective, multicentre, eastern European study.
Vokurka S; Bystrická E; Svoboda T; Škoda Gorican IK; Sever M; Mazur E; Kopinska A; Pavlicová V; Mocanu O; Tanase A; Ghelase R; Zítková M; Labudíková M; Raida L; Hrabánková-Navrátilová D; Bocková J
J Clin Nurs; 2014 Jun; 23(11-12):1648-52. PubMed ID: 24354726
[TBL] [Abstract][Full Text] [Related]
13. Disease Status at Transplant has a Significant Impact on Outcomes of Autologous Transplantation (ASCT) in Patients with Hodgkin Lymphoma-A Single Center Experience.
Senapati J; Devasia AJ; Korula A; Fouzia NA; Kulkarni U; Lakshmi KM; Lionel S; Abraham A; Srivastava A; Mathews V; George B
Indian J Hematol Blood Transfus; 2022 Apr; 38(2):290-298. PubMed ID: 35496963
[TBL] [Abstract][Full Text] [Related]
14. Safety and survival outcomes for bloodless transplantation in patients with myeloma.
Joseph NS; Kaufman JL; Boise LH; Valla K; Almaula DK; Obidike CO; Langston AA; Waller EK; Khoury HJ; Flowers CR; Graiser M; Heffner LT; Lonial S; Nooka AK
Cancer; 2019 Jan; 125(2):185-193. PubMed ID: 30480777
[TBL] [Abstract][Full Text] [Related]
15. Impact of Risk Factors and Long Term Survival Analysis of Patients With Primary Refractory Hodgkin Lymphoma Who Underwent High Dose Chemotherapy and Autologous Stem Cell Transplant.
Akhtar S; Rauf MS; Elhassan TAM; Khan ZA; Elshenawy MA; Maghfoor I
Transplant Cell Ther; 2023 Jul; 29(7):451.e1-451.e12. PubMed ID: 37031748
[TBL] [Abstract][Full Text] [Related]
16. HEMATOPOIETIC STEM CELL TRANSPLANT IN AGGRESSIVE T AND NK/T CELL LYMPHOMA - ROLE OF UPFRONT AUTOLOGOUS TRANSPLANT IN NODAL PERIPHERAL T-CELL LYMPHOMA.
Cheng Kiat Ng L; Shwei Wen Tham C; Wei Inng Lim F; Chen Y; Yeu Ong S; Nagarajan C; Lee JJ; Tee Goh Y; Linn YC; Shan Lee Y; Diong Phipps C; Kim Siang Quek J; Hein T; Cheng Hwang JC; Grigoropoulos N; Khee Hwang WY; Yew Leng Ho A
Blood Cell Ther; 2021 Nov; 4(4):92-100. PubMed ID: 36714065
[TBL] [Abstract][Full Text] [Related]
17. Nivolumab for adults with Hodgkin's lymphoma (a rapid review using the software RobotReviewer).
Goldkuhle M; Dimaki M; Gartlehner G; Monsef I; Dahm P; Glossmann JP; Engert A; von Tresckow B; Skoetz N
Cochrane Database Syst Rev; 2018 Jul; 7(7):CD012556. PubMed ID: 30001476
[TBL] [Abstract][Full Text] [Related]
18. LEAM vs. BEAM vs. CLV Conditioning Regimen for Autologous Stem Cell Transplantation in Malignant Lymphomas. Retrospective Comparison of Toxicity and Efficacy on 222 Patients in the First 100 Days After Transplant, On Behalf of the Romanian Society for Bone Marrow Transplantation.
Colita A; Colita A; Bumbea H; Croitoru A; Orban C; Lipan LE; Craciun OG; Soare D; Ghimici C; Manolache R; Gelatu I; Vladareanu AM; Pasca S; Teodorescu P; Dima D; Lupu A; Coriu D; Tomuleasa C; Tanase A
Front Oncol; 2019; 9():892. PubMed ID: 31552193
[TBL] [Abstract][Full Text] [Related]
19.
Conlon KC; Sportes C; Brechbiel MW; Fowler DH; Gress R; Miljkovic MD; Chen CC; Whatley MA; Bryant BR; Corcoran EM; Kurdziel KA; Pittaluga S; Paik CH; Lee JH; Fleisher TA; Carrasquillo JA; Waldmann TA
Cancer Biother Radiopharm; 2020 May; 35(4):249-261. PubMed ID: 32275165
[No Abstract] [Full Text] [Related]
20. Long-Term Outcomes and Safety Trends of Autologous Stem-Cell Transplantation in Non-Hodgkin Lymphoma: A Report From A Tertiary Care Center in India.
Kumar S; Sharma A; Pramanik R; Pathak N; Gogia A; Kumar A; Kayal S; Sharma V; Sahoo RK; Thulkar S; Sharma MC; Gupta R; Mallick S; Thomas M; Raina V
JCO Glob Oncol; 2022 May; 8():e2100383. PubMed ID: 35561291
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
